QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 期刊论文 AUTOPHAGY, 2021, 卷号: 17 作者:  Klionsky, Daniel J.;  Abdel-Aziz, Amal Kamal;  Abdelfatah, Sara;  Abdellatif, Mahmoud;  Abdoli, Asghar 收藏  |  浏览/下载：272/0  |  提交时间：2021/05/31 Autophagosome  cancer  flux  LC3  lysosome  macroautophagy  neurodegeneration  phagophore  stress  vacuole   Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial 期刊论文 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 卷号: 73, 期号: 4 作者:  Szarek, Michael;  White, Harvey D.;  Schwartz, Gregory G.;  Alings, Marco;  Bhatt, Deepak L. 收藏  |  浏览/下载：137/0  |  提交时间：2019/12/05 acute coronary syndrome  alirocumab  total events   Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2014, 卷号: 32, 期号: 30 作者:  du Bois, Andreas;  Floquet, Anne;  Kim, Jae-Weon;  Rau, Joern;  del Campo, Josep M. 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19 Genome-wide association study (GWAS) of pazopanib efficacy and safety in patients with ovarian cancer who have not progressed following first-line standard therapy. 期刊论文 2014, 卷号: 32, 期号: 15 作者:  Scambia, Giovanni;  Johnson, Toby;  Floquet, Anne;  Heitz, Florian;  Park, Sang-Yoon 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13 Genome-wide association study (GWAS) of pazopanib efficacy and safety in patients with ovarian cancer who have not progressed following first-line standard therapy. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2014-05-20 作者:  Scambia, Giovanni;  Johnson, Toby;  Floquet, Anne;  Heitz, Florian;  Park, Sang-Yoon 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13 Randomized, double-blind, phase III trial of pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (AEOC): Results of an international Intergroup trial (AGO-OVAR16). 会议论文 作者:  Du Bois, Andreas;  Floquet, Anne;  Kim, Jae Weon;  Rau, Joern;  Maria Del Campo, Jose 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19 Randomized, double-blind, phase III trial of pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced epithelial ovarian, Fallopian tube, or primary peritoneal cancer (AOC): Results of an international intergroup trial (AGO-OVAR16). 会议论文 作者:  Du Bois, Andreas;  Floquet, Anne;  Kim, Jae Weon;  Rau, Joern;  Del Campo, Jose Maria 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19